Korean J Reprod Med.  2010 Sep;37(3):253-259.

Growth Rate of Dominant Follicles During Controlled Ovarian Hyperstimulation

Affiliations
  • 1Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
  • 2Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University, Seoul, Korea.

Abstract


OBJECTIVE
To evaluate if there is any correlation between the growth rate of dominant follicles and clinical characteristics or outcome variables in women undergoing controlled ovarian hyperstimulation (COH). METHODS: This study was performed in 313 in vitro fertilization (IVF) cycles. Follicle stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E2) were measured on day 3 of menstrual cycle, and serial ultrasonographic measurement of the diameter of growing follicles was performed. The growth rates of dominant follicles calculated by diameter difference divided by days were correlated with clinical characteristics and outcome variables. RESULTS: There was no significant difference in the growth rate of the dominant follicles between gonadotropin releasing hormone (GnRH) agonist and antagonist cycles. No significant correlation was found between the growth rates and evaluated factors such as age, body mass index, LH, FSH, E2, retrieved oocytes and fertilization rate. CONCLUSION: The Growth rate of dominant follicles seems to show an independent feature of basal characteristics and ovarian response.

Keyword

Follicle growth; Controlled ovarian hyperstimulation

MeSH Terms

Body Mass Index
Estradiol
Female
Fertilization
Fertilization in Vitro
Follicle Stimulating Hormone
Gonadotropin-Releasing Hormone
Humans
Luteinizing Hormone
Menstrual Cycle
Oocytes
Estradiol
Follicle Stimulating Hormone
Gonadotropin-Releasing Hormone
Luteinizing Hormone
Full Text Links
  • KJRM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr